{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T10:01:39Z","timestamp":1773741699812,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,6]]},"DOI":"10.7759\/cureus.50064","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T21:20:35Z","timestamp":1701897635000},"source":"Crossref","is-referenced-by-count":1,"title":["Paradoxical Worsening of Pulmonary Hypertension Following Closure of Arteriovenous Fistula: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Abdul Muhsen Z","family":"Abdeen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zakaria","family":"Alagha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caleb","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amro","family":"Al-Astal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau G","year":"2019","unstructured":"Simonneau G, Montani D, Celermajer DS, et al.. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019, 53:10.1183\/13993003.01913-2018","journal-title":"Eur Respir J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2022.09.001","article-title":"Pulmonary hypertension mortality trends in United States 1999-2019","volume":"75","author":"Kang M","year":"2022","unstructured":"Kang M, Hart CM, Kempker JA, Veeraraghavan S, Trammell AW. Pulmonary hypertension mortality trends in United States 1999-2019. Ann Epidemiol. 2022, 75:47-52. 10.1016\/j.annepidem.2022.09.001","journal-title":"Ann Epidemiol"},{"key":"ref3","article-title":"Pulmonary hypertension","author":"Oldroyd SH","year":"2018","unstructured":"Oldroyd SH, Manek G, Sankari A, Bhardwaj A. Pulmonary hypertension. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2018."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2014.12.004","article-title":"Erratum regarding \"pulmonary hypertension in CKD\"","volume":"65","year":"2015","unstructured":"Erratum regarding \"pulmonary hypertension in CKD\". Am J Kidney Dis. 2015, 65.524. 10.1053\/j.ajkd.2014.12.004","journal-title":"Am J Kidney Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2020.04.039","article-title":"Pulmonary hypertension: a brief guide for clinicians","volume":"95","author":"Mandras SA","year":"2020","unstructured":"Mandras SA, Mehta HS, Vaidya A. Pulmonary hypertension: a brief guide for clinicians. Mayo Clin Proc. 2020, 95:1978-88. 10.1016\/j.mayocp.2020.04.039","journal-title":"Mayo Clin Proc"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11010132","article-title":"Carbon monoxide diffusion capacity as a severity marker in pulmonary hypertension","volume":"11","author":"Diamanti E","year":"2021","unstructured":"Diamanti E, Karava V, Yerly P, Aubert JD. Carbon monoxide diffusion capacity as a severity marker in pulmonary hypertension. J Clin Med. 2021, 11:10.3390\/jcm11010132","journal-title":"J Clin Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2020.11.002","article-title":"High output heart failure associated with arteriovenous fistula in the setting of kidney transplantation","volume":"6","author":"Chang RS","year":"2021","unstructured":"Chang RS, Hu JR, Beckman JA, Forbes RC, Shawar SH, Concepcion BP. High output heart failure associated with arteriovenous fistula in the setting of kidney transplantation. Kidney Int Rep. 2021, 6:544-51. 10.1016\/j.ekir.2020.11.002","journal-title":"Kidney Int Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.038505","article-title":"Effects of arteriovenous fistula ligation on cardiac structure and function in kidney transplant recipients","volume":"139","author":"Rao NN","year":"2019","unstructured":"Rao NN, Stokes MB, Rajwani A, et al.. Effects of arteriovenous fistula ligation on cardiac structure and function in kidney transplant recipients. Circulation. 2019, 139:2809-18. 10.1161\/CIRCULATIONAHA.118.038505","journal-title":"Circulation"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1542-4758.2012.00674.x","article-title":"The impact of arteriovenous fistula creation in pulmonary hypertension: measurement of pulmonary pressures by right heart catheterization in a patient with respiratory failure following arteriovenous fistula creation","volume":"16","author":"Poulikakos D","year":"2012","unstructured":"Poulikakos D, Theti D, Pau V, Banerjee D, Jones D. The impact of arteriovenous fistula creation in pulmonary hypertension: measurement of pulmonary pressures by right heart catheterization in a patient with respiratory failure following arteriovenous fistula creation. Hemodial Int. 2012, 16:553-5. 10.1111\/j.1542-4758.2012.00674.x","journal-title":"Hemodial Int"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1159\/000508957","article-title":"Prophylactic ligature of AV fistula prevents high output heart failure after kidney transplantation","volume":"51","author":"Hetz P","year":"2020","unstructured":"Hetz P, Pirklbauer M, M\u00fcller S, Posch L, Gummerer M, Tiefenthaler M. Prophylactic ligature of AV fistula prevents high output heart failure after kidney transplantation. Am J Nephrol. 2020, 51:511-9. 10.1159\/000508957","journal-title":"Am J Nephrol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/112972980901000305","article-title":"Effects of the arteriovenous fistula on pulmonary artery pressure and cardiac output in patients with chronic renal failure","volume":"10","author":"Beigi AA","year":"2009","unstructured":"Beigi AA, Sadeghi AM, Khosravi AR, Karami M, Masoudpour H. Effects of the arteriovenous fistula on pulmonary artery pressure and cardiac output in patients with chronic renal failure. J Vasc Access. 2009, 10:160-6. 10.1177\/112972980901000305","journal-title":"J Vasc Access"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01897-2018","article-title":"Pulmonary hypertension due to left heart\u00a0disease","volume":"53","author":"Vachi\u00e9ry JL","year":"2019","unstructured":"Vachi\u00e9ry JL, Tedford RJ, Rosenkranz S, et al.. Pulmonary hypertension due to left heart\u00a0disease. Eur Respir J. 2019, 53:1801897. 10.1183\/13993003.01897-2018","journal-title":"Eur Respir J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/2045893217716108","article-title":"Pulmonary hypertension in patients with chronic kidney disease: invasive hemodynamic etiology and outcomes","volume":"7","author":"O'Leary JM","year":"2017","unstructured":"O'Leary JM, Assad TR, Xu M, et al.. Pulmonary hypertension in patients with chronic kidney disease: invasive hemodynamic etiology and outcomes. Pulm Circ. 2017, 7:674-83. 10.1177\/2045893217716108","journal-title":"Pulm Circ"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2019.08.027","article-title":"Pulmonary hypertension subtypes and mortality in CKD","volume":"75","author":"Edmonston DL","year":"2020","unstructured":"Edmonston DL, Parikh KS, Rajagopal S, et al.. Pulmonary hypertension subtypes and mortality in CKD. Am J Kidney Dis. 2020, 75:713-24. 10.1053\/j.ajkd.2019.08.027","journal-title":"Am J Kidney Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-020-00355-0","article-title":"Prevalence and mortality of pulmonary hypertension in ESRD: a systematic review and meta-analysis","volume":"198","author":"Schoenberg NC","year":"2020","unstructured":"Schoenberg NC, Argula RG, Klings ES, Wilson KC, Farber HW. Prevalence and mortality of pulmonary hypertension in ESRD: a systematic review and meta-analysis. Lung. 2020, 198:535-45. 10.1007\/s00408-020-00355-0","journal-title":"Lung"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204610","article-title":"Pulmonary hypertension-targeted therapies in heart failure: a systematic review and meta-analysis","volume":"13","author":"Guay CA","year":"2018","unstructured":"Guay CA, Morin-Thibault LV, Bonnet S, Lacasse Y, Lambert C, Lega JC, Provencher S. Pulmonary hypertension-targeted therapies in heart failure: a systematic review and meta-analysis. PLoS One. 2018, 13:e0204610. 10.1371\/journal.pone.0204610","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01886-2017","article-title":"Macitentan in pulmonary hypertension due to left ventricular dysfunction","volume":"51","author":"Vachi\u00e9ry JL","year":"2018","unstructured":"Vachi\u00e9ry JL, Delcroix M, Al-Hiti H, et al.. Macitentan in pulmonary hypertension due to left ventricular dysfunction. Eur Respir J. 2018, 51:10.1183\/13993003.01886-2017","journal-title":"Eur Respir J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9149(99)80381-6","article-title":"Safety and efficacy of epoprostenol in patients with severe congestive heart failure","volume":"75","author":"Sueta CA","year":"1995","unstructured":"Sueta CA, Gheorghiade M, Adams KF Jr., et al.. Safety and efficacy of epoprostenol in patients with severe congestive heart failure. Am J Cardiol. 1995, 75:34A-43A. 10.1016\/s0002-9149(99)80381-6","journal-title":"Am J Cardiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2014.01.102","article-title":"PDE5 inhibitor sildenafil in the treatment of heart failure: a meta-analysis of randomized controlled trials","volume":"172","author":"Zhuang XD","year":"2014","unstructured":"Zhuang XD, Long M, Li F, Hu X, Liao XX, Du ZM. PDE5 inhibitor sildenafil in the treatment of heart failure: a meta-analysis of randomized controlled trials. Int J Cardiol. 2014, 172:581-7. 10.1016\/j.ijcard.2014.01.102","journal-title":"Int J Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/193600-paradoxical-worsening-of-pulmonary-hypertension-following-closure-of-arteriovenous-fistula-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:08:46Z","timestamp":1707509326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/193600-paradoxical-worsening-of-pulmonary-hypertension-following-closure-of-arteriovenous-fistula-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,6]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.50064","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,6]]}}}